Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00001152 · ClinicalTrials.gov registry record
Pigment Dispersion Syndrome With and Without Glaucoma
A clinical trial of Glaucoma and Ocular Hypertension, sponsored by National Eye Institute (NEI).
- Completed
- Registry status
- 175
- Enrollment target
- 1
- Study location
NCT00001152 is a study of Glaucoma and Ocular Hypertension that has completed, run by National Eye Institute (NEI). The registered enrollment target is 175 participants, below the 909-participant average among 92 other Glaucoma trials with a reported enrollment target (81% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00001152, a study of Glaucoma and Ocular Hypertension, has completed, sponsored by National Eye Institute (NEI).
- COMPLETED
- Registry status
- 175 participants
- Enrollment target
- 1
- Study location
Study Summary
To compare patients having PDS without and with OH or GL by documenting and following the clinical features and course of their disease and evaluating the patient's performance on a variety of diagnostic tests.
Conditions Studied
Study Locations (1)
Maryland
- National Eye Institute (NEI) - Bethesda
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 175 participants |
| Start Date | 1976-06 |
| Est. Completion | 2000-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00001152
The ClinicalTrials.gov registry entry for NCT00001152 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 175 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 909-participant average among 92 other Glaucoma trials with a reported enrollment target (81% lower). The listed sponsor is National Eye Institute (NEI), which has 221 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Glaucoma appearing as the primary indexed condition, and to 0 interventions.
NCT00001152 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.
Frequently Asked Questions
What is clinical trial NCT00001152 about?
NCT00001152 is a clinical study titled "Pigment Dispersion Syndrome With and Without Glaucoma". To compare patients having PDS without and with OH or GL by documenting and following the clinical features and course of their disease and evaluating the patient's performance on a variety of diagnostic tests.
What is the current status of trial NCT00001152?
This trial is currently completed. The enrollment target is 175 participants. The study started on 1976-06. Estimated completion is 2000-06.
What conditions does trial NCT00001152 study?
This clinical trial studies the following conditions: Glaucoma, Ocular Hypertension, Glaucoma Open-Angle.
Who is sponsoring clinical trial NCT00001152?
This trial is sponsored by National Eye Institute (NEI), which has 221 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00001152 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Glaucoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Functional and Structural Imaging for Glaucoma
RECRUITING
-
Topical Insulin for Glaucoma
RECRUITING · Phase 1
-
Village-Integrated Eye Worker Trial II
RECRUITING · NA
-
Phase 2 Study of BL1107 Eye Drops vs. Timolol in Adults With Primary Open Angle Glaucoma or Ocular Hypertension
RECRUITING · Phase 2
-
Eye Pressure Lowering Surgery
RECRUITING
-
Tolerability of an Anesthesia-free Tonometer Tip
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.